Delivery Order 75N94024D00003-75N94026F00001
Award Date 12/18/25
Potential Completion Date 5/31/26
Potential Value $92K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Tonawanda, NY 14150, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the Department of Health and Human Services, awarded a $44,606.40 firm fixed-price purchase order to Pine Pharmaceuticals LLC, a small business contractor located in Tonawanda, New York. The contract is for the acquisition of intravenous stable isotopes, specifically D5 glycerol and 6,6 D2-glucose, to support metabolic research. This award is not associated with a larger contract vehicle. The contract has a...
- This is a $81,714.96 firm fixed-price delivery order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services, to Pine Pharmaceuticals LLC, a for-profit limited liability company located in Tonawanda, New York. The contract is for the provision of intravenous stable isotope glucose (D5 glycerol) to support metabolic research. The contract has an ultimate completion date of April 30,...
- The National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a $237,922.80 firm fixed price purchase order to Pine Pharmaceuticals LLC. The purpose of this acquisition is to procure an intravenous stable isotope to support metabolic research studies being conducted by the funding agency. The solicitation sought a stable isotope that meets NIH specifications for use in clinical human research, referencing a history of safe use in such studies. No...
- This is a firm-fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), an agency within the U.S. Department of Health and Human Services (HHS), to Pine Pharmaceuticals LLC for the procurement of intravenous stable isotope (6,6 D2-Glucose) for metabolic research. The $138,712.14 contract has an ultimate completion date of November 2, 2024 and was awarded on a sole-source basis without a small business set-aside. Pine Pharmaceuticals is an...
- This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the U.S. Department of Health and Human Services, to Pine Pharmaceuticals LLC, a for-profit limited liability company located in Tonawanda, New York. The $12,580.80 contract is for the acquisition of intravenous stable isotopes, which are specialized pharmaceutical compounds used in metabolic and clinical research studies. Pine Pharmaceuticals is an...
- This is a $15,000 firm fixed-price delivery order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services (HHS), to Pine Pharmaceuticals LLC, a for-profit limited liability company. The contract is for the provision of non-severable task order 1 for metabolic isotopes to support research studies conducted by various HHS agencies. Pine Pharmaceuticals is an FDA-registered 503B...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), an institute within the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS), awarded a $14,400 firm fixed-price purchase order contract to Cambridge Isotope Laboratories, Inc., doing business as Cambridge Isotope Labs, located in Tewksbury, Massachusetts. The contract is for the delivery of D-glucose to support NIDDK research programs and will be performed from September 11-30,...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), awarded a $51,625 purchase order to Sigma-Aldrich, Inc. of St. Louis, Missouri. Under the terms of the contract, Sigma-Aldrich will provide glucose isotopes to NIDDK in support of its biomedical research efforts. Performance will take place in St. Louis over a two-month period concluding in late September...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded a $24,686.75 firm fixed-price contract to Government Scientific Source Inc., a small business based in Reston, Virginia, through a Blanket Purchase Agreement (BPA) call for deuterium oxide filtered to 99.8 atom percent deuterium per quote #Q493231. The contract, designated as a total small business set-aside, was awarded on September 28, 2022, with performance to be completed in Herndon, Virginia by March 31, 2023....
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) awarded a $39,000 firm-fixed-price purchase order to Cambridge Isotope Laboratories, Inc. (CIL) for the delivery of deuterium oxide, D-glucose, glycerol, and other labeled compounds in support of biomedical research programs. CIL, a manufacturer of stable isotopes and isotopically labeled compounds, has provided similar labeled materials to NIH institutes like the...